The Report Guru

The growth of the autotransfusion devices market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood. According to research report Autotransfusion Systems Market is projected to reach USD 505 million by 2024 from USD 395 million in 2019 at a CAGR of 5.0%. Autotransfusion products, by type, accounted for the largest share of the autotransfusion market, in 2019. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141903480 North America, by region, held the largest share of the autotransfusion systems market in 2019. The large share of the North American market can mainly be attributed to the high and growing prevalence of target health conditions (cardiovascular, orthopedic, and trauma cases), increasing number of major transplant procedures, scarcity of allogenic blood, preference for autologous blood (due to its advantages),...

  According to research report Autotransfusion Systems Market is projected to reach USD 505 million by 2024 from USD 395 million in 2019 at a CAGR of 5.0%. Autotransfusion products, by type, accounted for the largest share of the autotransfusion systems market, in 2019. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141903480 The growth of the autotransfusion devices market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood. Medtronic Plc (Ireland), Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc (US), Teleflex Incorporated (US), LivaNova (UK), Fresenius (Germany), Atrium Medical Corporation (Sweden), Haemonetics Corporation (US), SARSTEDT (Germany), Braile Biomédica (Brazil), Redax (Italy), Beijing ZKSK Technology Co (China), and Gen World Medical Devices (India) are some of the leading players. ...

The growth of Autotransfusion Systems Market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood. What the Market Looks Like? Predicted to grow at a CAGR of 5.0% during the forecast period, the global Autotransfusion Systems Market is projected to reach USD 505 million by 2024 from USD 395 million in 2019. North America, by region, held the largest share of the market in 2019. Since type, the Autotransfusion Systems Market is segmented into autotransfusion products & accessories. The autotransfusion products segment accounted for the largest share of the market in 2019. Autotransfusion products are associated with several advantages, which are expected to boost its adoption in the coming years. These components prevent the transmission of transfusion-related blood-borne diseases in patients, and they also provide more compatible blood in comparison to autolog...